Next Tuesday, June 20 will be held an informative session on “Funding opportunities in health of the HORIZON EUROPE PROGRAMME”, focusing especially on the new calls of the Health Cluster and an exchange of experiences where different IDIVAL researchers will talk about their participation in European projects.
This event is organized by the European projects area of IDIVAL and the Spanish Foundation for Science and Technology (FECYT). A day of great interest for both researchers and technicians, which will help R&D staff to keep up to date on new funding opportunities in European health.
The conference will be held on Tuesday, June 20 at 10:00 am in the Gómez-Durán Room of the Marqués de Valdecilla University Hospital. We would be grateful if you could reserve this date in your diaries and share the event among the members of the research groups.
For any questions please contact the European projects office of IDIVAL:
Tlfn. 942 20 28 57
– Paloma González: innovacion4@idival.org
– María Luisa Sámano Celorio: proyectoseuropeos2@idival.org
– Natalia Puente: proyectos1@idival.org
Next Tuesday, June 20 will be held an informative session on “Funding opportunities in health of the HORIZON EUROPE PROGRAMME”, focusing especially on the new calls of the Health Cluster and an exchange of experiences where different IDIVAL researchers will talk about their participation in European projects. This event is organized by the European projects […]
More than 70 COST actions approved, an opportunity to establish international networks and contacts.
What are COST Actions?
COST Actions bring together professionals from various fields, with the aim of collaborating on research topics. These actions attract researchers and innovators from universities, public and private institutions, NGOs, industry and SMEs. In addition, it is important to note that participants can apply at any stage of their career.
What does a COST action finance?
Participation in a COST action has a duration of 4 years, which is estimated to be sufficient time for the establishment of these collaborative networks, and the financial support is mainly intended to finance travel, subsistence and accommodation, as well as short stays in European centers.
What are the approved COST actions?
There are currently 70 COST actions available, which are listed at the end of this message.
Who to contact?
If you wish to have more information about COST, please contact the European projects team and they will be happy to inform and advise you about these and many other European initiatives.
Contact us:
Paloma González innovacion4@idival.org
Natalia Puente proyectos1@idival.org
Maria Sámano proyectoseuropeos2@idival.org
In the following link you can consult the Approved actions and more information about each of them: Approved COST actions
List of approved COST actions:
CA22103 A Comprehensive Network Against Brain Cancer
CA22111 A European consortium to determine how complex, real-world environments influence brain development
CA22114 Maternal Perinatal Stress and Adverse Outcomes in the Offspring: Maximising infants´development
CA22116 The Great Leap. Multidisciplinary approaches to health inequalities, 1800-2022
CA22118 Radionuclide theragnostics for personalised medicine
CA22119 Haemoglobinopathies in European Liaison of Medicine and Science
CA22125 Precision medicine in biliary tract cancer
CA22128 Establishing Networks to Implement the Principles on Effective Interviewing for Investigations
CA22152 Supporting emerging care economy, empowering caregivers to provide safe care at home
CA22159 National, International and Transnational Histories of Healthcare, 1850-2000
CA22162 FUTUREforMED: a transdisciplinary network to bridge climate science and impacts on society
CA22169 EUropean network to tackle METAbolic alterations in HEART failure
CA22170 TEndon Regeneration NETwork
More than 70 COST actions approved, an opportunity to establish international networks and contacts. What are COST Actions? COST Actions bring together professionals from various fields, with the aim of collaborating on research topics. These actions attract researchers and innovators from universities, public and private institutions, NGOs, industry and SMEs. In addition, it is […]New COST actions aimed at promoting research and innovation collaboration between countries
The study, published in the prestigious scientific journal, opens the door to the development of new treatments
Researchers from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) are participating in an international genetic study published in the journal Nature that reveals new therapeutic targets that could facilitate the development of new treatments to treat COVID-19 infection.
The study, led by researchers from the United Kingdom in collaboration with three international consortia, has counted with the participation of José Antonio Riancho, coordinator of the study in the region in Cantabria, and the infectious diseases, pneumology or immunology services of HUMV together with numerous research centers, universities and Spanish hospitals.
More than 20,000 cases of patients with COVID-19 were examined in order to explore the relationship of genetic differences in different cohorts of patients with severe complications of the infection. The analysis identified 49 gene variants of which 16 were previously unknown. These results help to better understand the mechanisms of the interaction between the virus causing the infection and the human organism, which could open the door to the development of new systems for predicting the severity of the disease.
The identification of these variants has been possible thanks to a genome-wide association study (GWAS) and the analysis of nearly one million genetic variations known as single nucleotide polymorphisms (SNPs). Comparison of the data in patients with severe COVID-19, patients with mild disease and healthy individuals has provided new insights into susceptibility to different types of the virus, confirming the relevance of genetics to the prognosis and severity of infection.
Some of these genetic variants are found in “actionable” genes, whose activity can be modified by various drugs. These include, for example, genes of the JAK signaling pathway, genes that modulate macrophage activation and vascular permeability (PDE4A), or genes involved in virus entry and replication (such as TMPRSS2 and RAB2A). These results could also help to establish new therapeutic strategies.
An international study
The project, led by the University of Edinburgh, involved three international consortia GenOMICC UK, ISARIC4C and SCOURGE. The aim of SCOURGE, funded by the Instituto de Salud Carlos III, is to analyze biomarkers of evolution and prognosis that can have an immediate impact on clinical management and therapeutic decisions in patients with the virus.
The study, published in the prestigious scientific journal, opens the door to the development of new treatments Researchers from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) are participating in an international genetic study published in the journal Nature that reveals new therapeutic targets that could facilitate the […]
Spinocerebellar ataxia type 15 (SCA15), characterized by alterations in the strength, speed and dexterity of movements, is the disease on which the genetic study that could help in its diagnosis and treatment in the future has focused.
Neurologists and geneticists from different centers have participated in the research, including the researcher José Berciano from the Neurology Department of the Marqués de Valdecilla University Hospital (HUMV) and the Neurodegenerative Diseases Group of the Marqués de Valdecilla Health Research Institute (IDIVAL), the University of Cantabria and the Center for Biomedical Research Network on Neurodegenerative Diseases (CIBERNED).
Researchers from the Hospital Clínico Universitario Lozano Blesa and the Hospital Universitario Miguel Servet, both in Zaragoza, where the first author of this work, Dr. José Gazulla, is integrated.
The results of this study show a greater genetic variety of spinocerebellar ataxia type 15 (SCA15) than previously known. This disease normally presents a significant loss of genetic material compared to healthy individuals due to alterations in a gene called ITPR1. However, this study identified 4 cases of patients with symptoms and 2 presymptomatic patients, both carriers of specific genetic alterations. Several unaffected family members who also did not carry this type of alteration were also analyzed.
Until now, only 2 cases of point mutations had been documented, so the study, published in the prestigious European Journal of Neurology, expands the possibilities of diagnosis and future treatments.
The study included an extensive clinical analysis of patients and their relatives, genetic studies and an extensive literature review to compare the results with those published in the medical literature.
Teamwork will continue in the future to collaborate in the research of neurodegenerative diseases such as heredoataxias and hereditary diseases with neurological involvement.
Spinocerebellar ataxia type 15 (SCA15), characterized by alterations in the strength, speed and dexterity of movements, is the disease on which the genetic study that could help in its diagnosis and treatment in the future has focused. Neurologists and geneticists from different centers have participated in the research, including the researcher José Berciano from the […]
Next Thursday, June 1 will take place the general session entitled “Approach to Delirium in the elderly” given by Dr. Barbara Perez, attending physician of the Geriatrics Service of the University Hospital Marqués de Valdecilla.
The session will take place at the Marqués de Valdecilla University Hospital, Gómez Durán Hall at 8:15 am.
Next Thursday, June 1 will take place the general session entitled “Approach to Delirium in the elderly” given by Dr. Barbara Perez, attending physician of the Geriatrics Service of the University Hospital Marqués de Valdecilla. The session will take place at the Marqués de Valdecilla University Hospital, Gómez Durán Hall at 8:15 am.
Next Thursday, June 1 will take place the general session entitled “Approach to Delirium in the elderly” given by Dr. Barbara Perez, attending physician of the Geriatrics Service of the University Hospital Marqués de Valdecilla.
The session will take place at the Marqués de Valdecilla University Hospital, Gómez Durán Hall at 8:15 am.
Next Thursday, June 1 will take place the general session entitled “Approach to Delirium in the elderly” given by Dr. Barbara Perez, attending physician of the Geriatrics Service of the University Hospital Marqués de Valdecilla. The session will take place at the Marqués de Valdecilla University Hospital, Gómez Durán Hall at 8:15 am.
The objective of this call is to promote the transfer of knowledge in the Autonomous Community of Cantabria, understanding knowledge transfer as the set of activities aimed at the dissemination of knowledge, experience and skills in order to facilitate the use, application and exploitation of knowledge and capabilities in R&T of the university and research centers outside the academic environment, either by other R&T institutions, the productive sector or society in general.
The maximum amount of the call is 200,000 euros.
The grant will be awarded for the amount corresponding to the cost of the actions that are accredited as necessary for the proper implementation of the project, with a maximum limit of 20,000 euros per project.
Beneficiaries
Public companies, public business entities and foundations attached to or dependent on the Autonomous Community of Cantabria, as well as any other entity belonging to the autonomous public sector of the Autonomous Community of Cantabria, which are in the situation that justifies the granting of the subsidy.
The purpose of the subsidies is to provide economic assistance to public entities that promote the transfer of knowledge.
This knowledge transfer can adopt any of the following modalities:
– Transfer of knowledge derived from the realization of Final Degree, Final Master or Industrial Doctorate works of interest for the end user of the knowledge transfer.
– Transfer of knowledge derived from the realization of collaborative Research Projects between the agent that develops the knowledge and the potential end user of the same.
Documentation
The application shall be accompanied by the Descriptive Report of the Project according to the model that will be published as an Annex together with the call, as well as an estimated list of eligible expenses corresponding to the period to which the call refers, also formalized in the official model that will be published as an Annex to the respective call.
The application shall be accompanied by an Annex-Responsible declaration in accordance with the model that will be published together with the call for applications.
The application shall be accompanied by an estimate of eligible expenses corresponding to the period to which the call refers, in accordance with the model of Annex-Estimation of eligible expenses that will be published together with the call.
25
The applications must be signed by the representative of the entity, formalized in the official model that is published in the Annex in the call.
Applications may be submitted up to one month from the day following the publication of this extract of this call in the Official Gazette of Cantabria (25/05/2023).
Applications may be submitted at the Common Electronic Register https://rec.cantabria.es/rec/bienvenida.htm or at cBOC Cantabria (25/05/2023)
The objective of this call is to promote the transfer of knowledge in the Autonomous Community of Cantabria, understanding knowledge transfer as the set of activities aimed at the dissemination of knowledge, experience and skills in order to facilitate the use, application and exploitation of knowledge and capabilities in R&T of the university and research […]
An opportunity to train and gain experience in research management in a health institute accredited by the Instituto de Salud Carlos III.
The GES-VAL program for the training of research managers aims to promote the professional practice and training of technicians in aspects related to the management and support of research, by learning aspects related to the management, monitoring and evaluation of research promotion activities, as well as internationalization and innovation activities in the field of health sciences and technologies.
1 temporary employment contract is announced for the development of activities in the field of research management in the scientific production unit of the Institute. An opportunity to get to know the IDIVAL Institute, its organization and management, developing functions related to the management and updating of the Institute’s scientific production databases. The research portal is a fundamental tool that makes the Institute’s research visible at national and international level. Among other functions to be developed will be to support in the updating of information systems in the bibliometric field, exploitation of information systems and the database for the preparation of documentation, reports and scientific production reports and contact with researchers to advise them and provide support in the field of scientific production.
The internship contract will have a duration of 12 months, counting from the date of incorporation, the trial period will be two months. The selected candidate will develop a tutored training itinerary, with periodic evaluations and presentation of a report at the end of the first year.
Requisitos de los candidatos
First cycle university graduates are eligible for the Ges-Val program. In all cases, these must be official Spanish degrees and, if they have been obtained abroad, they must be officially recognized on the date of the deadline for submitting applications, in accordance with the applicable regulations.
The contract may be entered into with those in possession of the required university degree, provided that no more than five years have elapsed, or seven, when the contract is entered into with a disabled worker, from the completion of the studies to the start of the contract, and that they have not previously entered into another internship contract in possession of the same degree.
Required documentation
Together with the application, applicants must submit the following documentation:
a) Curriculum vitae in CVA format
Standardized curriculum vitae reduced version FECYT, available at: https://cvn.fecyt.es/ and on the IDIVAL intranet.
b) Report of the proposal of the activities to be carried out by the candidate.
It should reflect the candidate’s interests and include general references to the different IDIVAL support areas, with a more detailed description of those that adapt to the candidate’s profile and interests: project area, training and methodological support area, clinical trials area, technological services area, innovation area and general services area. For the purposes of the evaluation process, only the information contained in the corresponding curriculum vitae and reports will be taken into account on the closing date of the application submission period. Failure to submit these within the deadline will not be correctable and will result in the exclusion of the application during the admission phase.
c) Copy of the DNI.
d) Official academic certification of the studies completed, with details of the subjects taken and the grades obtained, and, where appropriate, a copy of the academic degree.
e) Documentary accreditation of the curricular merits provided (certificate of employment, credentials of the candidate, course certificates stating the duration of the same, etc.), without which requirement they will not be taken into consideration.
Submission of applications until June 17
Solicitudes: https://aplicacionesidival.idival.org/ConvocatoriasPropias/es/Convocatorias/VerConvocatoria?Id=1009
An opportunity to train and gain experience in research management in a health institute accredited by the Instituto de Salud Carlos III. The GES-VAL program for the training of research managers aims to promote the professional practice and training of technicians in aspects related to the management and support of research, by learning aspects related […]
An excellent opportunity to train in the clinical trials unit of Hospital Valdecilla, a reference unit in clinical trials in northern Spain, which has a team of highly experienced professionals.
In the ordinary call TEC-VAL has been a vacancy so this program is reconvened with the same rules as the previous one.
The training program for research support technicians Valdecilla “TEC-VAL” is a training program that promotes professional practice and training of technicians in aspects related to research support in the field of various support services platforms IDIVAL, which in this call 2023 are specifically directed to the Clinical Trials Unit Valdecilla.
The internship contract will have a duration of 12 months, counting from the date of incorporation. The selected candidate will develop a tutored training itinerary, with periodic evaluations and presentation of a report at the end of the first year.
The TEC-Val program is open to first cycle university graduates. In all cases, these must be official Spanish degrees and, if they have been obtained abroad, they must be officially recognized on the date of the deadline for submitting applications, in accordance with the applicable regulations.
The contract may be entered into with those in possession of the required degree, provided that no more than five years have elapsed, or seven, when the contract is entered into with a disabled worker, since the completion of the studies and that they have not previously accessed another internship contract while in possession of the same degree.
Documentation to be submitted:
Together with the application, applicants must submit the following documentation:
a) Curriculum vitae in CVA format
Standardized curriculum vitae in reduced version FECYT, available at: https://cvn.fecyt.es/ and on the IDIVAL intranet.
b) Report of the proposed activities to be carried out by the candidate.
It should include a proposal of the activities to be carried out by the candidate and include general references to the different support services units of IDIVAL, with a more detailed description of those that fit the profile and interests of the candidate: referred to the clinical trials unit or the technological services (biobank or microscopy unit) IDIVAL. For the purposes of the evaluation process, only the information contained in the corresponding curriculum vitae and reports will be taken into account on the closing date of the application submission period. Failure to submit these documents by the deadline will not be correctable and will result in the exclusion of the application during the admission phase.
c) Copy of the DNI.
d) Official academic certification of the studies completed, with details of the subjects taken and grades obtained, and, where appropriate, a copy of the academic degree. corresponding sworn translation.
e) Documentary accreditation of the curricular merits provided (certificate of employment, credentials of the candidate, course certificates stating the duration of these, etc.), without which requirement they will not be taken into consideration.
Submission of applications: until June 17.
Application: https://aplicacionesidival.idival.org/ConvocatoriasPropias/es/Convocatorias/VerConvocatoria?Id=1008
An excellent opportunity to train in the clinical trials unit of Hospital Valdecilla, a reference unit in clinical trials in northern Spain, which has a team of highly experienced professionals. In the ordinary call TEC-VAL has been a vacancy so this program is reconvened with the same rules as the previous one. The training program […]
